M12 Share Price Performance
€13.96
-2.44 (-14.88%)
Price €13.96
Share Price€13.96
Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business
Jun 13
M1 Kliniken AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
M12 Community Narratives
There are no narratives available yet.
M1 Kliniken AG Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.86
- Gross Margin
- 12.80%
- Net Profit Margin
- 4.72%
- Debt/Equity Ratio
- 8.0%
M1 Kliniken AG Competitors
Snowflake Analysis
About M12
- Founded
- 2007
- Employees
- 199
- CEO
- WebsiteView website
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdominoplastic and nose correction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
German Market Performance
- 7 Days: 1.5%
- 3 Months: -1.0%
- 1 Year: 14.5%
- Year to Date: 13.8%
The market is up 1.5% over the last week, with the Industrials sector leading the way, up 2.7%. In the last year, the market has climbed 15%. Looking forward, earnings are forecast to grow by 17% annually. Market details ›